Skip to content

InMode AG606666A

by Inmode MD, Ltd.

InMode AG606666A is a multi-modality skin surface treatment system (FDA Class II) made by Inmode MD, Ltd., cleared under FDA 510(k) K240017 on 13 Jun 2024 (1 earlier submission) and listed in FDA GUDID since 14 Mar 2017 (UDI-DI 07290016633252), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK240017 Date13 Jun 2024DecidedStatusActive
United StatesGUDID listing Number07290016633252 UDI-DI Date14 Mar 2017ListedStatusListed GUDID: in commercial distribution

Official records

Across registries

2 registries list this device

  • FDA 510(k) K240017 decided 13 Jun 2024 Active· +1 more in the status table
  • FDA GUDID UDI-DI 07290016633252 listed 14 Mar 2017 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K123682
  2. Listed FDA GUDID 07290016633252
  3. Cleared FDA 510(k) K240017

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
InMode
Generic name
Multi-modality skin surface treatment system
Model / Ref / Catalog
AG606666A
Primary DI / UDI-DI
07290016633252
510(k) Number
FDA product code
GEX, GEI
GMDN term
Multi-modality skin surface treatment system
Device class
Class II
Regulation number
878.4810, 878.4400
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Multi-modality skin surface treatment system.

Other devices from Inmode MD, Ltd.

See all devices from Inmode MD, Ltd. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)